What is the basis for a genetic approach in neonatal disorders?

Seminars in Perinatology

Volumn 39, Issue 8, 2015, Pages 568-573

  Bhandari, Vineet ^a   Gruen, Jeffrey R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apnea of prematurity; BPD; IVH; NEC; Neonatal sepsis; PDA; Premature newborn; RDS; ROP; Twin studies

Indexed keywords

BRAIN HEMORRHAGE; GENETIC ANALYSIS; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HUMAN; LUNG DYSPLASIA; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN APNEA; NEWBORN DISEASE; NEWBORN SEPSIS; NONHUMAN; PATENT DUCTUS ARTERIOSUS; PHENOTYPE; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TWINS; ADAPTIVE IMMUNITY; BREAST MILK; BRONCHOPULMONARY DYSPLASIA; DRUG EFFECTS; ENTEROCOLITIS, NECROTIZING; FEMALE; GENETICS; IMMUNOLOGY; INFANT; INFANT MORTALITY; INTERMITTENT POSITIVE PRESSURE VENTILATION; MALE; NEWBORN; NEWBORN INTENSIVE CARE; PRACTICE GUIDELINE; PREGNANCY; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETINOPATHY OF PREMATURITY; SEPSIS; TIME FACTOR; TREATMENT OUTCOME;

GLUCOCORTICOID; LUNG SURFACTANT;

ADAPTIVE IMMUNITY; BRONCHOPULMONARY DYSPLASIA; ENTEROCOLITIS, NECROTIZING; FEMALE; GENE-ENVIRONMENT INTERACTION; GLUCOCORTICOIDS; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE; INTENSIVE CARE, NEONATAL; INTERMITTENT POSITIVE-PRESSURE VENTILATION; MALE; MILK, HUMAN; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETINOPATHY OF PREMATURITY; SEPSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84946731339     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2015.09.003     Document Type: Review

References (57)

1. Lackritz E.M., Wilson C.B., Guttmacher A.E., et al. A solution pathway for preterm birth: accelerating a priority research agenda. Lancet Glob Health 2013, 1(6):e328-e330.
2. Yoshida S., Rudan I., Lawn J.E., et al. Newborn health research priorities beyond 2015. Lancet 2014, 384(1):e27-e29.
3. Bhandari V., Gruen J.R. The genetics of bronchopulmonary dysplasia. Semin Perinatol 2006, 30(4):185-191.
4. Meng H., Gruen J.R. Genetic approaches to complications of prematurity. Front Biosci 2007, 12:2344-2351.
5. American Lung Association (ALA). Respiratory Distress Syndrome and Bronchopulmonary Dysplasia. Lung Disease Data 2008. 2008.
6. Mahoney A.D., Jain L. Respiratory disorders in moderately preterm, late preterm, and early term infants. Clin Perinatol 2013, 40(4):665-678.
7. Fraser J., Walls M., McGuire W. Respiratory complications of preterm birth. Br Med J 2004, 329(4):962-965.
8. Jo H.S. Genetic risk factors associated with respiratory distress syndrome. Korean J Pediatr 2014, 57(4):157-163.
9. Levit O., Jiang Y., Bizzarro M.J., et al. The genetic susceptibility to respiratory distress syndrome. Pediatr Res 2009, 66(6):693-697.
10. Myrianthopoulos N.C., Churchill J.A., Baszynski A.J. Respiratory distress syndrome in twins. Acta Genet Med Gemellol (Roma) 1971, 20(2):199-204.
11. van Sonderen L., Halsema E.F., Spiering E.J., Koppe J.G. Genetic influences in respiratory distress syndrome: a twin study. Semin Perinatol 2002, 26(6):447-449.
12. Marttila R., Haataja R., Ramet M., Lofgren J., Hallman M. Surfactant protein B polymorphism and respiratory distress syndrome in premature twins. Hum Genet 2003, 112(1):18-23.
13. Marttila R., Kaprio J., Hallman M. Respiratory distress syndrome in twin infants compared with singletons. Am J Obstet Gynecol 2004, 191(1):271-276.
14. Prosnitz A., Gruen J.R., Bhandari V. The genetics of disorders affecting the premature newborn. Emery and Rimoin's Principles and Practice of Medical Genetics 2013, 1-22. Elsevier. 6th ed. D.L. Rimoin, J.M. Connor, P.R.E. KBR (Eds.).
15. Chock V.Y., Punn R., Oza A., et al. Predictors of bronchopulmonary dysplasia or death in premature infants with a patent ductus arteriosus. Pediatr Res 2014, 75(4):570-575.
16. Sellmer A., Bjerre J.V., Schmidt M.R., et al. Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3. Arch Dis Child Fetal Neonatal Ed 2013, 98(6):F505-F510.
17. Bhandari V., Zhou G., Bizzarro M.J., et al. Genetic contribution to patent ductus arteriosus in the premature newborn. Pediatrics 2009, 123(2):669-673.
18. Herskind A.M., Almind Pedersen D., Christensen K. Increased prevalence of congenital heart defects in monozygotic and dizygotic twins. Circulation 2013, 128(11):1182-1188.
19. Dagle J.M., Lepp N.T., Cooper M.E., et al. Determination of genetic predisposition to patent ductus arteriosus in preterm infants. Pediatrics 2009, 123(4):1116-1123.
20. McCrea H.J., Ment L.R. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol 2008, 35(4):777-792. [vii].
21. Bhandari V., Bizzarro M.J., Shetty A., et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006, 117(6):1901-1906.
22. Shankaran S., Lin A., Maller-Kesselman J., et al. Maternal race, demography, and health care disparities impact risk for intraventricular hemorrhage in preterm neonates. J Pediatr 2014, 164(5):1005-1011.e3.
23. Viscardi R.M., Donn S.M., Rayburn W.F., Schork M.A. Intraventricular hemorrhage in preterm twin gestation infants. J Perinatol 1988, 8(2):114-117.
24. Perlman J.M., Broyles R.S., Rogers C.G. Neonatal neurologic characteristics of preterm twin infants <1,250 gm birth weight. Pediatr Neurol 1997, 17(4):322-326.
25. Ryckman K.K., Dagle J.M., Kelsey K., Momany A.M., Murray J.C. Replication of genetic associations in the inflammation, complement, and coagulation pathways with intraventricular hemorrhage in LBW preterm neonates. Pediatr Res 2011, 70(1):90-95.
26. Poggi C., Giusti B., Vestri A., Pasquini E., Abbate R., Dani C. Genetic polymorphisms of antioxidant enzymes in preterm infants. J Matern Fetal Neonatal Med 2012, 25(Suppl. 4):131-134.
27. Ment L.R., Aden U., Lin A., et al. Gene-environment interactions in severe intraventricular hemorrhage of preterm neonates. Pediatr Res 2014, 75(1-2):241-250.
28. Bloch-Salisbury E., Hall M.H., Sharma P., Boyd T., Bednarek F., Paydarfar D. Heritability of apnea of prematurity: a retrospective twin study. Pediatrics 2010, 126(4):e779-e787.
29. Elder D.E., Campbell A.J., Galletly D. Current definitions for neonatal apnoea: are they evidence based?. J Paediatr Child Health 2013, 49(9):E388-E396.
30. Di Fiore J.M., Martin R.J., Gauda E.B. Apnea of prematurity-perfect storm. Respir Physiol Neurobiol 2013, 189(2):213-222.
31. Tamim H., Khogali M., Beydoun H., Melki I., Yunis K., National Collaborative Perinatal Neonatal Network Consanguinity and apnea of prematurity. Am J Epidemiol 2003, 158(10):942-946.
32. Chen A.C., Chung M.Y., Chang J.H., Lin H.C. Pathogenesis implication for necrotizing enterocolitis prevention in preterm very-low-birth-weight infants. J Pediatr Gastroenterol Nutr 2014, 58(1):7-11.
33. Sampath V., Le M., Lane L., et al. The NFKB1 (g.-24519delATTG) variant is associated with necrotizing enterocolitis (NEC) in premature infants. J Surg Res 2011, 169(1):e51-e57.
34. Prencipe G., Azzari C., Moriondo M., et al. Association between mannose-binding lectin gene polymorphisms and necrotizing enterocolitis in preterm infants. J Pediatr Gastroenterol Nutr 2012, 55(2):160-165.
35. Chan K.Y., Leung K.T., Tam Y.H., et al. Genome-wide expression profiles of necrotizing enterocolitis versus spontaneous intestinal perforation in human intestinal tissues: dysregulation of functional pathways. Ann Surg 2014, 260(6):1128-1137.
36. Asano M.K., Dray P.B. Retinopathy of prematurity. Dis Mon 2014, 60(6):282-291.
37. Hellstrom A., Smith L.E., Dammann O. Retinopathy of prematurity. Lancet 2013, 382(9902):1445-1457.
38. Zin A., Gole G.A. Retinopathy of prematurity-incidence today. Clin Perinatol 2013, 40(2):185-200.
39. Holmstrom G., van Wijngaarden P., Coster D.J., Williams K.A. Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies. Br J Ophthalmol 2007, 91(12):1704-1708.
40. Azad R., Chandra P., Patwardhan S.D., Gupta A. Profile of asymmetrical retinopathy of prematurity in twins. Indian J Ophthalmol 2010, 58(3):209-211.
41. Bizzarro M.J., Hussain N., Jonsson B., et al. Genetic susceptibility to retinopathy of prematurity. Pediatrics 2006, 118(5):1858-1863.
42. Bhandari A., Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics 2009, 123(6):1562-1573.
43. Jensen E.A., Schmidt B. Epidemiology of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol 2014, 100(3):145-157.
44. Bhandari A., Bhandari V. New Bronchopulmonary Dysplasia: a clinical review. Clin Pulm Med 2011, 18(3):137-143.
45. Parker R.A., Lindstrom D.P., Cotton R.B. Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia. Semin Perinatol 1996, 20(3):206-209.
46. Lavoie P.M., Pham C., Jang K.L. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics 2008, 122(3):479-485.
47. Wang H., Julien K.R., Stevenson D.K., et al. A genome-wide association study (GWAS) for bronchopulmonary dysplasia. Pediatrics 2013, 132(2):290-297.
48. Hoffmann T.J., Shaw G.M., Stevenson D.K., et al. Copy number variation in bronchopulmonary dysplasia. Am J Med Genet A 2014, 164A(10):2672-2675.
49. Shaw G.M., O'Brodovich H.M. Progress in understanding the genetics of bronchopulmonary dysplasia. Semin Perinatol 2013, 37(2):85-93.
50. Fujioka K., Shibata A., Yokota T., et al. Association of a vascular endothelial growth factor polymorphism with the development of bronchopulmonary dysplasia in Japanese premature newborns. Sci Rep 2014, 4:4459.
51. Carrera P., Di Resta C., Volonteri C., et al. Exome sequencing and pathway analysis for identification of genetic variability relevant for bronchopulmonary dysplasia (BPD) in preterm newborns: A pilot study. Clin Chim Acta 2015, http://dx.doi.org/10.1016/j.cca.2015.01.001. [Epub ahead of print].
52. Bizzarro M.J., Jiang Y., Hussain N., Gruen J.R., Bhandari V., Zhang H. The impact of environmental and genetic factors on neonatal late-onset sepsis. J Pediatr 2011, 158(2):234-238.e1.
53. van der Zwet W.C., Catsburg A., van Elburg R.M., Savelkoul P.H., Vandenbroucke-Grauls C.M. Mannose-binding lectin (MBL) genotype in relation to risk of nosocomial infection in pre-term neonates in the neonatal intensive care unit. Clin Microbiol Infect 2008, 14(2):130-135.
54. Abu-Maziad A., Schaa K., Bell E.F., et al. Role of polymorphic variants as genetic modulators of infection in neonatal sepsis. Pediatr Res 2010, 68(4):323-329.
55. Esposito S., Zampiero A., Pugni L., et al. Genetic polymorphisms and sepsis in premature neonates. PLoS One 2014, 9(7):e101248.
56. Ambalavanan N., Cotten C.M., Page G.P., et al. Integrated genomic analyses in bronchopulmonary dysplasia. J Pediatr 2015, 166(3):531-537.e13.
57. Hadchouel A., Durrmeyer X., Bouzigon E., et al. Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. Am J Respir Crit Care Med 2011, 184(10):1164-1170.